CAR-T cell therapies targeting aspartyl β-hydroxylase (ASPH)

被引:0
|
作者
Thisted, Thomas [1 ]
Malhotra, Kanam [1 ]
Lebowitz, Michael S. [1 ]
Ghanbari, Hossein [1 ]
机构
[1] Sensei Biotherapeut, Gaithersburg, MD USA
关键词
D O I
10.1158/1538-7445.SABCS18-2306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2306
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies
    Kandav, Gurpreet
    Chandel, Akash
    MEDICAL ONCOLOGY, 2024, 41 (11)
  • [42] Neurotoxicity Associated with CD19-Targeted CAR-T Cell Therapies
    Juliane Gust
    Agne Taraseviciute
    Cameron J. Turtle
    CNS Drugs, 2018, 32 : 1091 - 1101
  • [43] Aspartyl β-hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin
    Dinchuk, JE
    Henderson, NL
    Burn, TC
    Huber, R
    Ho, SP
    Link, J
    O'Neil, KT
    Focht, RJ
    Scully, MS
    Hollis, JM
    Hollis, GF
    Friedman, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (50) : 39543 - 39554
  • [44] Engineering CAR-T therapies for autoimmune disease and beyond
    English, Emily P.
    Swingler, Rachel N.
    Patwa, Simran
    Tosun, Mehmet
    Howard Jr., James F.
    Miljkovic, Milos D.
    Jewell, Christopher M.
    SCIENCE TRANSLATIONAL MEDICINE, 2024, 16 (771)
  • [45] CAR-T and cellular gene therapies are too expensive
    Dropulic, Boro
    NATURE MEDICINE, 2024, : 2714 - 2714
  • [46] Emerging therapies using CAR-T cells in lymphoma
    Salles, Gilles
    Sesques, Pierre
    Ferrant, Emmanuelle
    Safar, Violaine
    Ghesquieres, Herve
    Bachy, Emmanuel
    BULLETIN DU CANCER, 2018, 105 : S168 - S177
  • [47] CAR-T Therapies in Solid Tumors: Opportunities and Challenges
    Guzman, Grace
    Reed, Megan R.
    Bielamowicz, Kevin
    Koss, Brian
    Rodriguez, Analiz
    CURRENT ONCOLOGY REPORTS, 2023, 25 (05) : 479 - 489
  • [48] CAR-T THERAPIES: REIMBURSEMENTS ABOUND, BUT WITH STRINGS ATTACHED
    Sutcliffe, D.
    Macaulay, R.
    Roibu, C.
    Dacosta, Fernandez R.
    VALUE IN HEALTH, 2020, 23 : S69 - S69
  • [49] CAR-T Therapies in Solid Tumors: Opportunities and Challenges
    Grace Guzman
    Megan R. Reed
    Kevin Bielamowicz
    Brian Koss
    Analiz Rodriguez
    Current Oncology Reports, 2023, 25 : 479 - 489
  • [50] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Ajeet Gajra
    Abigail Zalenski
    Aishwarya Sannareddy
    Yolaine Jeune-Smith
    Kandice Kapinos
    Ankit Kansagra
    Pharmaceutical Medicine, 2022, 36 : 163 - 171